Pulse of The Hill

Loading navigation…

Bill Detail

S. 3794

Congress: 119

2FLY-INS
1ISSUES

Title

SAFE Drugs Act of 2026

Summary

Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026 or the SAFE Drugs Act of 2026 This bill provides for increased oversight of drug compounding and imposes statutory limits on compounded drugs that are essentially copies of commercially available drugs. Currently, subject to certain requirements, compounded drugs (i.e., drugs that are mixed or altered to meet patient needs) do not require Food and Drug Administration (FDA) approval. Additional limits apply to the compounding of drugs that are essentially copies of commercially available drug products. Under the bill, a compounded drug is essentially a copy of a commercially available drug product if (1) the compounded drug contains any active ingredient found in a commercially available drug product, and (2) there is no change made for an individual patient that results in a significant difference between the compounded drug and the commercially available drug. (The FDA’s current definition of the term also addresses dosage strength and route of administration.) The bill increases the frequency at which a licensed pharmacist or physician may compound a drug that is essentially a copy of a commercially available drug to 20 times per month. Current FDA policy allows four such prescriptions per month. The bill also imposes annual reporting requirements on physicians, facilities, and pharmacies (except hospital-based pharmacies) that compound certain drug products for out-of-state patients more than 20 times per month. Further, the bill subjects certain large-scale outsourcing facilities (i.e., FDA-registered facilities that compound in bulk) to regular inspection and reporting requirements.

Sponsor

Sen. Jim Banks [R-IN]

Status

Placed on Senate Legislative Calendar under General Orders. Calendar No. 524.

Status as of Nov 15, 2026, 8:39 PM · synced 7h ago

Introduced

2026-02-05

Data source mode: cache

Linked fly-ins

2

Links match this bill’s Congress. A link is not a confirmed event agenda or attendee list.

Compounders on Capitol Hill 2026

Sep 14, 2026 – Sep 16, 2026 · The Ritz-Carlton Pentagon City, Arlington, VA (Capitol Hill visits)

Hosted by Alliance for Pharmacy Compounding

View

+ 1 more mobilizations in the full intelligence view

Bill Engagement

Lobbyists on the case

4 orgs · 13 lobbyists · 4 filings mention S. 3794 (SAFE Drugs Act of 2026) in LDA disclosures.

These are cached disclosure mentions, not verified current representation or confirmed event attendance.

Top orgs filing
Lobbyists on this bill
+ 11 more in the full intelligence view

Limited preview · paid intelligence

Keep the intelligence current—not just this one record.

Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.

Federal Intelligence is $2,500 one-time for three months, or $9,000 for twelve months prepaid, for one named user. Full tracked federal calendar, connected organization/bill/disclosure research, and a private workspace. Fixed terms; no automatic renewal. No demo or scope email is required for standard access.

SEE A FINISHED HEALTHCARE EXAMPLE

Three days of Hill visits. Two Medicare access questions.

A separate, source-linked editorial example—not a dossier about this bill, an endorsement, or a claim of participation. The full records stay paid.

Read the finished healthcare brief →
Buy Federal Intelligence · $2,500 for 3 monthsPrefer a walkthrough first?Already a customer? Sign inGet free intelligence alerts →

After verified successful payment, access is activated within one business day and a secure setup link is emailed. Your term starts at activation. These links do not charge you or unlock records. A free alert subscription does not grant full access.

Issue Areas

Healthcare

Trade Groups

ALLIANCE FOR PHARMACY COMPOUNDING